Corestreet Logo

Enliven Therapeutics Inc. (ELVN) Insider Trading

Total insider buys:
  • $0.00
Total insider sells:
  • $57,910,889.23
Most recent insider trade:
  • May 27, 2025
Most active insider trader:
  • Benjamin Hohl
Trader NameDateTitleAmountPriceTypeTotal Value
May 27, 2025CFO3,250$16.18Sell$52,585.00
May 19, 2025Insider5,000$16.31Sell$81,550.00
May 19, 2025CEO5,000$16.49Sell$82,450.00
May 7, 2025COO6,667$18.39Sell$122,606.13
May 1, 2025Insider5,030$20.07Sell$100,952.10
May 1, 2025CEO5,330$20.08Sell$107,026.40
April 28, 2025CFO3,250$18.69Sell$60,742.50
April 21, 2025Insider5,000$16.07Sell$80,350.00
April 17, 2025CEO5,000$16.42Sell$82,100.00
April 7, 2025COO6,667$18.04Sell$120,272.68
March 27, 2025CFO3,250$21.33Sell$69,322.50
March 24, 2025CFO1,000$22.50Sell$22,500.00
March 19, 2025Insider12,500$20.61Sell$257,625.00
March 17, 2025CEO12,500$20.83Sell$260,375.00
March 7, 2025COO6,667$21.44Sell$142,940.48
Feb. 27, 2025CFO3,250$20.41Sell$66,332.50
Feb. 7, 2025COO6,667$21.93Sell$146,207.31
Feb. 5, 2025CFO1,000$22.52Sell$22,520.00
Jan. 27, 2025CFO3,250$21.59Sell$70,167.50
Jan. 7, 2025COO21,700$24.18Sell$524,706.00
Jan. 3, 2025CFO1,000$25.04Sell$25,040.00
Dec. 30, 2024CFO900$22.51Sell$20,259.00
Dec. 27, 2024CFO3,350$22.15Sell$74,202.50
Nov. 27, 2024CFO5,250$24.89Sell$130,672.50
Oct. 28, 2024CFO6,250$28.56Sell$178,500.00
Oct. 18, 2024CEO924$30.00Sell$27,720.00
Oct. 18, 2024CFO814$30.00Sell$24,420.00
Oct. 18, 2024COO716$30.00Sell$21,480.00
Oct. 18, 2024Director817$30.00Sell$24,510.00
Oct. 18, 2024Insider847$30.00Sell$25,410.00
Oct. 15, 2024Director1,270$27.67Sell$35,140.90
Oct. 9, 2024CEO16,710$28.15Sell$470,386.50
Oct. 9, 2024Insider37,878$28.16Sell$1,066,644.48
Oct. 8, 2024Director10,420$28.17Sell$293,531.40
Oct. 7, 2024Insider2,707$27.61Sell$74,740.27
Oct. 7, 2024CEO2,730$27.50Sell$75,075.00
Oct. 7, 2024CFO1,270$27.51Sell$34,937.70
Oct. 4, 2024CFO10,218$27.51Sell$281,097.18
Oct. 4, 2024Insider7,522$27.51Sell$206,930.22
Oct. 4, 2024Director2,825$27.51Sell$77,715.75
Oct. 4, 2024CEO12,206$27.51Sell$335,787.06
Oct. 1, 2024CEO526$27.54Sell$14,486.04
Oct. 1, 2024Director518$27.54Sell$14,265.72
Oct. 1, 2024Insider527$27.54Sell$14,513.58
Sept. 30, 2024CFO2,000$25.33Sell$50,660.00
Sept. 27, 2024CFO4,250$24.27Sell$103,147.50
Aug. 29, 2024Insider12,000$22.49Sell$269,880.00
Aug. 27, 2024CFO4,250$22.54Sell$95,795.00
Aug. 26, 2024CEO12,000$22.89Sell$274,680.00
Aug. 15, 2024Director1,270$23.25Sell$29,527.50
First«1 of 3»Last

  • Insiders are selling Enliven Therapeutics Inc. stock.

  • The insider traders at Enliven Therapeutics Inc. are: Benjamin Hohl, Samuel Kintz, Anish Patel, Richard A Heyman, Joseph P Lyssikatos, Joseph P. Lyssikatos, Rahul D Ballal, 5Am Partners Vi, Llc, and Rishi Gupta

  • The most active insider trader at Enliven Therapeutics Inc. is Benjamin Hohl with 32 trades.

  • Rishi Gupta has sold the most Enliven Therapeutics Inc. stock with a total value of $45,754,524.00.

  • The most recent insider trade for Enliven Therapeutics Inc. was on May 27, 2025.

  • The single biggest insider sell for Enliven Therapeutics Inc. was from Rishi Gupta with a total value of $22,877,262.00 on May 16, 2024.